Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes
S. Jin, Yigang Hao, Zhenzhu Zhu, et al.
Inorganic Chemistry (2018) Vol. 57, Iss. 17, pp. 11135-11145
Closed Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Restraining Cancer Cells by Dual Metabolic Inhibition with a Mitochondrion‐Targeted Platinum(II) Complex
Kun Wang, Chengcheng Zhu, Yafeng He, et al.
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 14, pp. 4638-4643
Closed Access | Times Cited: 150
What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives
Kun Peng, Bing‐Bing Liang, Wenting Liu, et al.
Coordination Chemistry Reviews (2021) Vol. 449, pp. 214210-214210
Closed Access | Times Cited: 119
In Response to Precision Medicine: Current Subcellular Targeting Strategies for Cancer Therapy
Zheng Li, Jianhua Zou, Xiaoyuan Chen
Advanced Materials (2022) Vol. 35, Iss. 21
Closed Access | Times Cited: 74
Mitochondrion-targeted platinum complexes suppressing lung cancer through multiple pathways involving energy metabolism
Zhenzhu Zhu, Zenghui Wang, Changli Zhang, et al.
Chemical Science (2019) Vol. 10, Iss. 10, pp. 3089-3095
Open Access | Times Cited: 143
Activatable Mitochondria‐Targeting Organoarsenic Prodrugs for Bioenergetic Cancer Therapy
Xiangjie Luo, Xuanqing Gong, Liyun Su, et al.
Angewandte Chemie International Edition (2020) Vol. 60, Iss. 3, pp. 1403-1410
Closed Access | Times Cited: 101
Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity
Maria V. Babak, Zhi Yang, Bertrand Czarny, et al.
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 24, pp. 8109-8114
Open Access | Times Cited: 94
Platinum(IV) antitumor complexes and their nano-drug delivery
Chunyan Jia, Glen B. Deacon, Yingjie Zhang, et al.
Coordination Chemistry Reviews (2020) Vol. 429, pp. 213640-213640
Closed Access | Times Cited: 88
Interfering in apoptosis and DNA repair of cancer cells to conquer cisplatin resistance by platinum(iv) prodrugs
Shuren Zhang, Xuanmeng Zhong, Hao Yuan, et al.
Chemical Science (2020) Vol. 11, Iss. 15, pp. 3829-3835
Open Access | Times Cited: 72
A New Strategy to Fight Metallodrug Resistance: Mitochondria‐Relevant Treatment through Mitophagy to Inhibit Metabolic Adaptations of Cancer Cells
Meng‐Meng Wang, Fu‐Jie Xu, Yan Su, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 27
Closed Access | Times Cited: 55
The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022
Shihao Su, Yutong Chen, Pengfei Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114680-114680
Closed Access | Times Cited: 43
Manganese(ii) complexes stimulate antitumor immunity via aggravating DNA damage and activating the cGAS-STING pathway
Linxiang Cai, Ying Wang, Yayu Chen, et al.
Chemical Science (2023) Vol. 14, Iss. 16, pp. 4375-4389
Open Access | Times Cited: 28
Overcoming Cancer Resistance to Platinum Drugs by Inhibiting Cholesterol Metabolism
Ying Wang, Linxiang Cai, Hui Li, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 42
Closed Access | Times Cited: 27
Ruthenium(II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death
Gurunath Sahu, Sushree Aradhana Patra, Sudhir Lima, et al.
Chemistry - A European Journal (2023) Vol. 29, Iss. 18
Open Access | Times Cited: 25
Iridium(III)-Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy
Dongping Deng, Mengmeng Wang, Yan Su, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6810-6821
Closed Access | Times Cited: 9
TPP-based conjugates: potential targeting ligands
Sanya Batheja, Shruti Gupta, Kiran Kumar Tejavath, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 6, pp. 103983-103983
Closed Access | Times Cited: 9
Mitochondria as a Novel Target for Cancer Chemoprevention: Emergence of Mitochondrial-targeting Agents
Mofei Huang, Charles R. Myers, Yian Wang, et al.
Cancer Prevention Research (2020) Vol. 14, Iss. 3, pp. 285-306
Open Access | Times Cited: 65
Dithiocarbazate–FeIII, −CoIII, −NiII, and −ZnII Complexes: Design, Synthesis, Structure, and Anticancer Evaluation
Yi Gou, Xiaoying Jia, Li Hou, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 9, pp. 6677-6689
Closed Access | Times Cited: 33
Mitochondria as a target of third row transition metal-based anticancer complexes
Chibuzor Olelewe, Samuel G. Awuah
Current Opinion in Chemical Biology (2022) Vol. 72, pp. 102235-102235
Open Access | Times Cited: 29
Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity
Sainath Babaji Aher, J. Zhu, Pundlik Rambhau Bhagat, et al.
Topics in Current Chemistry (2024) Vol. 382, Iss. 1
Closed Access | Times Cited: 7
Targeting Energy Metabolism by a Platinum(IV) Prodrug as an Alternative Pathway for Cancer Suppression
S. Jin, Yan Guo, Dongfan Song, et al.
Inorganic Chemistry (2019) Vol. 58, Iss. 9, pp. 6507-6516
Closed Access | Times Cited: 52
Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy
Gang Yang, Zhengyin Pan, Dongyang Zhang, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 39, pp. 43444-43455
Closed Access | Times Cited: 43
Fighting metallodrug resistance through alteration of drug metabolism and blockage of autophagic flux by mitochondria-targeting AIEgens
Yan Su, Hai Lin, Ying Tu, et al.
Chemical Science (2022) Vol. 13, Iss. 5, pp. 1428-1439
Open Access | Times Cited: 23
Multifunctional Iridium(III)–Platinum(IV) Conjugates as Potent Anticancer Theranostic Agents
Ajay Gupta, Abhishek Pandey, Titas Mondal, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8687-8704
Closed Access | Times Cited: 15
Triarylphosphine-Coordinated Bipyridyl Ru(II) Complexes Induce Mitochondrial Dysfunction
Richard J. Mitchell, Anitha S. Gowda, Alexander G. Olivelli, et al.
Inorganic Chemistry (2023) Vol. 62, Iss. 28, pp. 10940-10954
Closed Access | Times Cited: 13
Self‐Assembled Metal Complexes in Biomedical Research
Wenting Wang, Yang Xu, Yuqi Tang, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top